Marketing-authorisation holder · Brazil
Mawdsleys Pharmaceuticals do Brasil Ltda
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATENSINA | Clonidine | Brazil | Authorised | 2022 |
| DIPATE | Thiotepa | Brazil | Authorised | 2024 |
| KYTRIL | Granisetron | Brazil | Authorised | 2025 |
| LEUSTATIN | Cladribine | Brazil | Authorised | 2022 |
| WILLENTINE | Dicloridrato trientina | Brazil | Authorised | 2021 |
| PERSANTIN | Dipyridamole | Brazil | Cancelled | 2020 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 6 | 5 |